Characteristics of the study population
| Characteristic | Cases (n=1886) |
| Age (years) | 65.2 (±10.6) |
| Sex (% male) | 53.6 |
| BMI (kg/m2) | 30.5 (±5.4) |
| HDL cholesterol (mmol/L) | 1.17 (±0.32) |
| Non-HDL cholesterol (mmol/L) | 3.12 (±0.90) |
| Never smoked (%) | 23.3 |
| Former smoker (%) | 50.7 |
| Current smoker (%) | 16.2 |
| MAP (mm Hg) | 98.9 (±10.8) |
| HbA1c (%) | 7.0 (±1.1) |
| HbA1c (mmol/L) | 53.31 (11.58) |
| Duration type 2 diabetes at inclusion (years) | 10.1 (±8.4) |
| Duration of follow-up (years) | 6.9 (±2.1) |
| eGFR change during total follow-up (%) | −7.7 (±24.5) |
| eGFR change per year (%) | −2.3 (±24.9) |
| ACR change during total follow-up (%) | 800.5 (±3626.8) |
| ACR change per year (%) | 162.2 (±678.5) |
| Normoalbuminuria (ACR <30 mg/g) (%) | 90.5 |
| Microalbuminuria (ACR 30–300 mg/g) (%) | 2.8 |
| Macroalbuminuria (ACR >300 mg/g) (%) | 0.2 |
| Normoalbuminuria at follow-up (%) | 79.2 |
| Microalbuminuria at follow-up (%) | 5.5 |
| Macroalbuminuria at follow-up (%) | 0.2 |
Unless stated otherwise, mean (±SD) are given.
ACR, albumin-to-creatinine ratio; BMI, body mass index; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; MAP, mean arterial pressure.